It is noteworthy that tumor infiltration by lymphocytes indicated an antitumor response of breast cancer, and the level of tumor-infiltrating lymphocytes (TILs) was associated with a better outcome in HER2-positive cancers [62,63]. This evidence concerns the gene ERBB2 and neoplasm.